Jiangsu Hengrui Pharmaceuticals Co.,Ltd (HKG:1276)

HKG:1276 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	417,860	310,587	316,838	277,811	396,571	702,753
Market Cap Growth	35.75%	-1.97%	14.05%	-29.95%	-43.57%	62.99%
Enterprise Value	372,648	286,905	298,159	258,198	375,624	684,268
PE Ratio	51.20	46.06	66.85	62.91	71.32	93.51
PS Ratio	12.34	10.43	12.60	11.55	12.47	21.34
PB Ratio	6.37	6.33	7.01	6.40	9.08	19.22
P/TBV Ratio	6.59	6.58	7.27	6.59	9.35	19.62
P/FCF Ratio	39.06	53.52	46.69	-	126.49	205.64
P/OCF Ratio	32.00	39.32	37.63	194.22	76.58	172.42
EV/Sales Ratio	10.60	9.63	11.86	10.74	11.81	20.78
EV/EBITDA Ratio	38.10	37.48	55.89	63.46	71.83	85.74
EV/EBIT Ratio	42.05	41.63	64.81	74.65	81.29	91.87
EV/FCF Ratio	34.83	49.44	43.94	-	119.81	200.23
Debt / Equity Ratio	0.00	0.00	0.00	0.04	0.00	-
Debt / EBITDA Ratio	0.01	0.02	0.02	0.37	0.04	-
Debt / FCF Ratio	0.01	0.02	0.01	-	0.06	-
Net Debt / Equity Ratio	-0.67	-0.54	-0.51	-0.43	-0.52	-0.53
Net Debt / EBITDA Ratio	-4.71	-3.47	-4.29	-4.59	-4.36	-2.44
Net Debt / FCF Ratio	-4.13	-4.58	-3.37	22.71	-7.27	-5.71
Asset Turnover	0.53	0.60	0.53	0.52	0.70	0.89
Inventory Turnover	1.61	1.64	1.50	1.44	1.80	1.98
Quick Ratio	5.95	8.62	10.74	7.36	7.72	6.70
Current Ratio	6.55	9.72	12.25	8.50	8.88	7.44
Return on Equity (ROE)	14.34%	14.55%	10.77%	10.31%	13.51%	22.64%
Return on Assets (ROA)	8.37%	8.62%	6.06%	4.69%	6.36%	12.59%
Return on Invested Capital (ROIC)	32.36%	27.67%	18.16%	15.12%	23.90%	44.61%
Return on Capital Employed (ROCE)	12.90%	13.90%	10.10%	7.90%	10.50%	20.30%
Earnings Yield	1.95%	2.17%	1.50%	1.59%	1.40%	1.07%
FCF Yield	2.56%	1.87%	2.14%	-0.30%	0.79%	0.49%
Payout Ratio	17.06%	20.12%	23.77%	26.00%	23.54%	16.07%
Buyback Yield / Dilution	-1.59%	-0.15%	1.20%	-0.36%	0.18%	0.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.